Characterization of β-adrenoceptor subtype in bladder smooth muscle in cynomolgus monkey

被引:24
作者
Takeda, H
Yamazaki, Y
Akahane, M
Akahane, S
Miyata, H
Igawa, Y
Nishizawa, O
机构
[1] Kissei Pharmaceut Co Ltd, Cent Res Lab, Div Discovery Res, Nagano 3998304, Japan
[2] Shinshu Univ, Sch Med, Dept Urol, Matsumoto, Nagano 3908621, Japan
关键词
beta-adrenoceptor; beta(3)-adrenoceptor; monkey; detrusor; bladder;
D O I
10.1254/jjp.88.108
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We first investigated the relaxations of the urinary bladder induced by beta-adrenoceptor agonists in anesthetized cynomolgus monkeys and then employed a variety of beta-adrenoceptor agonists and antagonists in vitro to identify the beta-adrenoceptor subtype responsible for the relaxation (using isolated monkey detrusors). Isoprenaline reduced bladder pressure in a dose-dependent manner. Isoprenaline, noradrenaline and adrenaline each produced a concentration-dependent relaxation of isolated detrusor strips, the rank order of relaxing potencies being isoprenaline>noradrenaline>adrenaline. Subtype-selective beta-adrenoceptor agonists also relaxed isolated detrusor strips, the rank order of potencies being CGP-12177>BRL37344>dobutamine, salbutamol, procaterol>xamoterol. In the antagonist experiment, bupranolol (beta-antagonist, 10(-6) to 10(-5) M) and SR 58894A (beta(3)-antagonist, 10(-7) to 10(-5) M) caused a rightward shift of the concentration-relaxation curve for isoprenaline, but CGP-20712A (beta(1)-antagonist. 10(-9) to 10(-7) M) and ICI-118551 (beta(2)-antagonist, 10(-9) to 10(-7) M) did not. The present functional Study provides the first evidence that relaxation of the monkey detrusor by beta-adrenoceptor activation is mediated via the beta(3)-subtype.
引用
收藏
页码:108 / 113
页数:6
相关论文
共 19 条
[1]  
ANDERSON GF, 1984, J PHARMACOL EXP THER, V228, P283
[2]   Advances in the pharmacological control of the bladder [J].
Andersson, KE .
EXPERIMENTAL PHYSIOLOGY, 1999, 84 (01) :195-213
[3]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[4]   In vitro inhibition of human colonic motility with SR 59119A and SR 59104A:: evidence of a β3-adrenoceptor-mediated effect [J].
Bardou, M ;
Dousset, B ;
Deneux-Tharaux, C ;
Smadja, C ;
Naline, E ;
Chaput, JC ;
Naveau, S ;
Manara, L ;
Croci, T ;
Advenier, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 353 (2-3) :281-287
[5]  
DePonti F, 1996, BRIT J PHARMACOL, V117, P1374
[6]   MOLECULAR CHARACTERIZATION OF THE HUMAN BETA-3-ADRENERGIC RECEPTOR [J].
EMORINE, LJ ;
MARULLO, S ;
BRIENDSUTREN, MM ;
PATEY, G ;
TATE, K ;
DELAVIERKLUTCHKO, C ;
STROSBERG, AD .
SCIENCE, 1989, 245 (4922) :1118-1121
[7]  
Igawa Y, 1998, ACTA PHYSIOL SCAND, V164, P117
[8]   Functional and molecular biological evidence for a possible β3-adrenoceptor in the human detrusor muscle [J].
Igawa, Y ;
Yamazaki, Z ;
Takeda, H ;
Hayakawa, K ;
Akahane, M ;
Ajisawa, Y ;
Yoneyama, T ;
Nishizawa, O ;
Andersson, KE .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (03) :819-825
[9]   (-)-CGP 12177-induced increase of human atrial contraction through a putative third beta-adrenoceptor [J].
Kaumann, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (01) :93-98
[10]   POSSIBLE MECHANISMS OF BETA-ADRENOCEPTOR-MEDIATED RELAXATION INDUCED BY NORADRENALINE IN GUINEA-PIG TAENIA CECUM [J].
KOIKE, K ;
HORINOUCHI, T ;
TAKAYANAGI, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 279 (2-3) :159-163